AM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
AM is not a good aggressive buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some supportive technical structure and positive analyst target revisions, but the broader setup is mixed: insider and hedge fund selling, weak latest-quarter revenue, no recent news catalyst, and no Intellectia proprietary buy signal. If you want income and gradual long-term exposure to midstream infrastructure, AM is acceptable to hold or start only a small position, but based on the current data it is not a clear buy-now candidate.
Price closed at 21.26, essentially flat on the session. The trend is mildly constructive: SMA_5 > SMA_20 > SMA_200, which is bullish, and MACD histogram is slightly positive at 0.0103, though contracting, suggesting momentum is fading. RSI_6 at 36.34 is neutral-to-soft and does not show strong upside pressure. Price is sitting near support and below pivot (21.519), with S1 at 20.917 and R1 at 22.121. Overall, the chart says the stock is still in an up-biased structure, but short-term momentum is not strong enough to call it a compelling immediate entry.
The company also appears to benefit from the market's preference for durable EBITDA growth in midstream infrastructure. The current technical structure remains above the 200-day average, and options positioning is bullish. As a midstream name, AM also remains tied to defensive cash-flow and dividend-style investor demand.
There is no recent news catalyst from the past week. Hedge funds are selling aggressively and insider selling has also increased, which is a negative signal for near-term confidence. The latest quarter showed revenue dropping sharply year over year, and gross margin collapsed to zero in the snapshot provided, which weakens the fundamental growth case. The stock trend model also points to weakness over the next week and month, suggesting limited near-term upside from current levels.
In Q1 2026, the company reported a severe revenue decline to -21.21 million, down 107.29% YoY, which is a weak top-line trend. Net income was 118.27 million, down 1.93% YoY, while EPS was flat at 0.25. The latest quarter does not show meaningful growth acceleration. For a long-term beginner investor, the financial snapshot is more consistent with a stable income-oriented midstream name than a growth story.
Analyst sentiment has improved over the last few months. Morgan Stanley upgraded the stock to Equal Weight from Underweight and lifted its target to $26 from $20. UBS raised its target to $24 while staying Neutral, and Goldman Sachs raised its target to $23 while keeping Neutral. The overall Wall Street view is mixed-to-slightly positive: pros like the durable EBITDA growth profile, sector upside, and better long-term growth strategy, but cons include valuation limits and a still-cautious rating profile rather than a broad bullish consensus.
